New study tests Under-the-Tongue tablet to ward off Kids' winter colds

NCT ID NCT07578012

Recruiting now Prevention Sponsor: Lallemand Pharma AG Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests whether PMBL® sublingual tablets can reduce the number of respiratory infections (like colds) in children aged 3 to 12 who are prone to getting sick. Half the children will receive the active tablet, and half will receive a placebo (inactive tablet) for 3 months, with 4 more months of follow-up. The goal is to see if the treatment lowers infection rates and antibiotic use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY CHILDREN RESPIRATORY TRACT INFECTIONS (RTI)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Alergo-Med Specjalistyczna Przychodnia
RECRUITING

Tarnów, Poland
Allergotest
RECRUITING

Lublin, Poland
Bio Zdrowie
RECRUITING

Bialystok, Poland
Centrum Nowoczesnych Terapii
RECRUITING

Krakow, Poland
Comarch Healthcare S.A.
NOT_YET_RECRUITING

Krakow, Poland
In Vivo Sp. z o.o.
RECRUITING

Bydgoszcz, Poland
Linden Sp. z o.o. sp.k.
RECRUITING

Krakow, Poland
Med - Polonia
RECRUITING

Poznan, Poland
Medicome Sp. z o.o.
RECRUITING

Oświęcim, Poland
Vitamed
RECRUITING

Bydgoszcz, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.